These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12426658)

  • 21. Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psychometric parameters and pain.
    Haus U; Varga B; Stratz T; Späth M; Müller W
    Scand J Rheumatol Suppl; 2000; 113():55-8. PubMed ID: 11028833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, placebo-controlled trial of a single dose of tropisetron for the prevention of vomiting after strabismus surgery in children.
    Tosun Z; Akin A; Dogan H; Boyaci A
    Mt Sinai J Med; 2006 Dec; 73(8):1106-11. PubMed ID: 17285204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of 5-HT3 receptor antagonists in various rheumatic diseases--a clue to the mechanism of action of these agents in fibromyalgia?
    Stratz T; Müller W
    Scand J Rheumatol Suppl; 2000; 113():66-71. PubMed ID: 11028836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunomodulatory function of the 5-HT3 receptor antagonist tropisetron.
    Schneider EM; Ma X; Stratz T; Müller W; Lorenz I; Seeling WD
    Scand J Rheumatol Suppl; 2004; 119():34-40. PubMed ID: 15515411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analgesic effects of 5-HT3 receptor antagonists.
    Riering K; Rewerts C; Zieglgänsberger W
    Scand J Rheumatol Suppl; 2004; 119():19-23. PubMed ID: 15515407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study on the efficacy of ELA-Max (4% liposomal lidocaine) compared with EMLA cream (eutectic mixture of local anesthetics) using thermosensory threshold analysis in adult volunteers.
    Tang MB; Goon AT; Goh CL
    J Dermatolog Treat; 2004 Apr; 15(2):84-7. PubMed ID: 15204157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous treatment of fibromyalgia with the 5-HT3 receptor antagonist tropisetron in a rheumatological practice.
    Tolk J; Kohnen R; Müller W
    Scand J Rheumatol Suppl; 2004; 119():72-5. PubMed ID: 15515420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway.
    Vega Lde L; Muñoz E; Calzado MA; Lieb K; Candelario-Jalil E; Gschaidmeir H; Färber L; Mueller W; Stratz T; Fiebich BL
    Biochem Pharmacol; 2005 Aug; 70(3):369-80. PubMed ID: 15922994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of fibromyalgia with tropisetron, a 5HT3 serotonin antagonist: a pilot study.
    Papadopoulos IA; Georgiou PE; Katsimbri PP; Drosos AA
    Clin Rheumatol; 2000; 19(1):6-8. PubMed ID: 10752491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin type 3 receptor antagonist tropisetron in the treatment of chronic inflammatory rheumatic conditions--preliminary clinical experience.
    Hrycaj P
    Scand J Rheumatol Suppl; 2004; 119():55-8. PubMed ID: 15515416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of chronic low back pain with tropisetron.
    Stratz T; Müller W
    Scand J Rheumatol Suppl; 2004; 119():76-8. PubMed ID: 15515421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sub-anesthetic doses of bupivacaine or lidocaine increase peripheral ICS-205 930-induced analgesia against inflammatory pain in rats.
    Giordano J; Sacks SM
    Eur J Pharmacol; 1997 Sep; 334(1):39-41. PubMed ID: 9346325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: a comparison of efficacy, side-effect profile, and cost.
    Abali H; Celik I
    Cancer Invest; 2007; 25(3):135-9. PubMed ID: 17530482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of the 5-hydroxytryptamine (5HT3) receptor antagonist ICS 205-930 in the carcinoid syndrome.
    Coupe MO; Anderson JV; Morris JA; Alstead EM; Bloom SR; Hodgson HJ
    Aliment Pharmacol Ther; 1988 Apr; 2(2):167-72. PubMed ID: 2979242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-HT3 receptor antagonist for the treatment of tendinopathy.
    Mousavizadeh K; Stratz T; Mueller W; Fiebich BL
    Nat Clin Pract Rheumatol; 2008 Jul; 4(7):E4. PubMed ID: 18597984
    [No Abstract]   [Full Text] [Related]  

  • 36. Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients.
    Weisshaar E; Dunker N; Röhl FW; Gollnick H
    Exp Dermatol; 2004 May; 13(5):298-304. PubMed ID: 15140020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-inflammatory effects of 5-HT receptor antagonist, tropisetron on experimental colitis in rats.
    Mousavizadeh K; Rahimian R; Fakhfouri G; Aslani FS; Ghafourifar P
    Eur J Clin Invest; 2009 May; 39(5):375-83. PubMed ID: 19302562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of the lateral hypothalamus produces antinociception mediated by 5-HT1A, 5-HT1B and 5-HT3 receptors in the rat spinal cord dorsal horn.
    Holden JE; Farah EN; Jeong Y
    Neuroscience; 2005; 135(4):1255-68. PubMed ID: 16165284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of eutectic mixture of local anesthetics during lumbar puncture in newborns.
    Kaur G; Gupta P; Kumar A
    Arch Pediatr Adolesc Med; 2003 Nov; 157(11):1065-70. PubMed ID: 14609894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraarticular administration of ketorolac, morphine, and ropivacaine combined with intraarticular patient-controlled regional analgesia for pain relief after shoulder surgery: a randomized, double-blind study.
    Axelsson K; Gupta A; Johanzon E; Berg E; Ekbäck G; Rawal N; Enström P; Nordensson U
    Anesth Analg; 2008 Jan; 106(1):328-33, table of contents. PubMed ID: 18165599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.